You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prurigo Nodularis

Showing 1 - 25 of 35
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dupilumab in Prurigo Nodularis: An Observational Study

Not yet recruiting
  • Prurigo Nodularis
  • (no location specified)
Aug 7, 2023

Prurigo Nodularis Trial (Dupilumab SAR231893 (REGN668))

Not yet recruiting
  • Prurigo Nodularis
  • Dupilumab SAR231893 (REGN668)
  • (no location specified)
Oct 11, 2023

Prurigo Nodularis Trial (Ruxolitinib Cream, Vehicle Cream)

Not yet recruiting
  • Prurigo Nodularis
  • Ruxolitinib Cream
  • Vehicle Cream
  • (no location specified)
Mar 1, 2023

Prurigo Trial (Ruxolitinib Cream, Vehicle Cream)

Not yet recruiting
  • Prurigo
  • Ruxolitinib Cream
  • Vehicle Cream
  • (no location specified)
Feb 23, 2023

Prurigo Nodularis Trial in Austria, United States (Nemolizumab, Placebo)

Recruiting
  • Prurigo Nodularis
  • Irvine, California
  • +4 more
Aug 12, 2022

Prurigo Nodularis Trial in Germany, United States (CDX-0159, Normal saline)

Recruiting
  • Prurigo Nodularis
  • CDX-0159
  • Normal saline
  • Tempe, Arizona
  • +18 more
Jan 4, 2023

Disease Activity in Adolescents and Moderate to Severe

Not yet recruiting
  • Atopic Dermatitis
    • (no location specified)
    Jul 7, 2022

    China Type II Inflammatory Skin Disease Clinical Research and

    Recruiting
    • Atopic Dermatitis Eczema
    • Prurigo Nodularis
      • Beijing, China
        Peking University First Hospital
      Mar 29, 2022

      Prurigo Nodularis Trial in Worldwide (INCB054707, Placebo)

      Recruiting
      • Prurigo Nodularis
      • Phoenix, Arizona
      • +48 more
      Dec 1, 2022

      Transcriptomic Landscape of T Lymphocytes of Atopic Dermatitis,

      Unknown status
      • Prurigo Nodularis
      • Atopic Dermatitis
      • Skin biopsy
      • Plastic surgery remnants
      • (no location specified)
      Feb 6, 2021

      Prurigo Nodularis Trial in Germany (serlopitant, Placebo)

      Completed
      Has Results
      • Prurigo Nodularis
      • Berlin-Mitte, Germany
      • +14 more
      May 18, 2021

      Prurigo Nodularis, Pruritis Trial in Worldwide (vixarelimab, Placebo)

      Active, not recruiting
      • Prurigo Nodularis
      • Pruritis
      • Anniston, Alabama
      • +76 more
      Jan 3, 2023

      Prurigo Nodularis, Nodularis Prurigo, Prurigo Trial in Münster (nalbuphine HCl ER)

      Completed
      Has Results
      • Prurigo Nodularis
      • +2 more
      • nalbuphine HCl ER
      • Münster, Germany
        University of Münster
      Oct 5, 2020

      Prurigo Nodularis Trial in Worldwide (Nalbuphine ER Tablets, Matching Placebo Tablets)

      Active, not recruiting
      • Prurigo Nodularis
      • Nalbuphine ER Tablets
      • Matching Placebo Tablets
      • Phoenix, Arizona
      • +69 more
      Jan 31, 2023

      Prurigo Nodularis, Nodularis Prurigo, Prurigo Trial in Germany, Poland, United States (nalbuphine HCl ER tablets 90 mg BID,

      Completed
      Has Results
      • Prurigo Nodularis
      • +3 more
      • nalbuphine HCl ER tablets 90 mg BID
      • +2 more
      • Cleveland, Ohio
      • +3 more
      Oct 5, 2020

      Pruritus, Prurigo Nodularis Trial in Austria, Germany, Poland (5mg Serlopitant Tablets, Placebo Tablets)

      Completed
      Has Results
      • Pruritus
      • Prurigo Nodularis
      • 5mg Serlopitant Tablets
      • Placebo Tablets
      • Graz, Austria
      • +39 more
      May 18, 2021

      Prurigo Nodularis Trial in Worldwide (Nemolizumab 30 mg, Placebo)

      Recruiting
      • Prurigo Nodularis
      • Nemolizumab 30 mg
      • Placebo
      • Birmingham, Alabama
      • +109 more
      Jun 29, 2022

      Neurodermatitis Trial in Worldwide (Dupilumab SAR231893, Placebo, Moisturizers)

      Completed
      Has Results
      • Neurodermatitis
      • Dupilumab SAR231893
      • +4 more
      • Gilbert, Arizona
      • +62 more
      Nov 11, 2022

      Pruritus, Prurigo Nodularis Trial in United States (5mg Serlopitant Tablets, Placebo Tablets)

      Completed
      Has Results
      • Pruritus
      • Prurigo Nodularis
      • 5mg Serlopitant Tablets
      • Placebo Tablets
      • Birmingham, Alabama
      • +48 more
      May 18, 2021

      Keloid, Alopecia Areata, Acne Trial in Nashville (Corticosteroid with lidocaine, Corticosteroid with normal saline)

      Completed
      Has Results
      • Keloid
      • +14 more
      • Corticosteroid with lidocaine
      • Corticosteroid with normal saline
      • Nashville, Tennessee
        Vanderbilt University Medical Center
      Feb 18, 2021

      Neurodermatitis Trial in Worldwide (Dupilumab SAR231893, Placebo, Moisturizers)

      Completed
      • Neurodermatitis
      • Dupilumab SAR231893
      • +4 more
      • Fort Smith, Arkansas
      • +56 more
      Dec 2, 2021

      Prurigo Nodularis Trial in Worldwide (CD14152 Dose A, CD14152 )

      Completed
      Has Results
      • Prurigo Nodularis
      • CD14152 Dose A
      • CD14152 placebo
      • Graz, Austria
      • +15 more
      Feb 7, 2020

      Skin Disease in Methamphetamine Abuse

      Not yet recruiting
      • Methamphetamine Abuse
        • (no location specified)
        Jul 31, 2023

        Pruritus, Prurigo Nodularis, Atopic Dermatitis Trial in Worldwide (5 mg Serlopitant Tablets)

        Terminated
        Has Results
        • Pruritus
        • +3 more
        • 5 mg Serlopitant Tablets
        • Birmingham, Alabama
        • +84 more
        May 18, 2021

        Healthy Volunteers Trial in Tempe, Lincoln (Nemolizumab)

        Completed
        • Healthy Volunteers
        • Tempe, Arizona
        • +1 more
        Dec 13, 2022